Proximal tubule hypertrophy is an early response seen with the onset of diabetes, and in a streptozotocin model of type I diabetes, either erlotinib or selective proximal tubule deletion of EGFR expression reduced this early kidney hypertrophy. The gene discussed is EGFR; the disease is diabetes mellitus.